Subsequently, IgA-RF was shown to be associated with disease progression, worse outcome and extra-articular manifestations, such as interstitial lung disease and cardiovascular complications whereas such associations were not found or much less pronounced for IgM-RF. This evidence concerns the gene CD79A and interstitial lung disease.